Profile | GDS5420 / 215982_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 371.87 | 62 |
GSM1296119 | B_lesional_pre-dose | 144.52 | 46 |
GSM1296076 | C_lesional_pre-dose | 265.7 | 58 |
GSM1296092 | D_lesional_pre-dose | 455.09 | 67 |
GSM1296103 | E_lesional_pre-dose | 372.51 | 63 |
GSM1296078 | F_lesional_pre-dose | 214.95 | 55 |
GSM1296107 | G_lesional_pre-dose | 158.18 | 48 |
GSM1296109 | H_lesional_pre-dose | 238.77 | 54 |
GSM1296080 | I_lesional_pre-dose | 673.42 | 72 |
GSM1296090 | J_lesional_pre-dose | 436.43 | 66 |
GSM1296074 | K_lesional_pre-dose | 278.07 | 60 |
GSM1296111 | L_lesional_pre-dose | 104.29 | 40 |
GSM1296099 | M_lesional_pre-dose | 247.08 | 56 |
GSM1296086 | O_lesional_pre-dose | 381.86 | 64 |
GSM1296117 | P_lesional_pre-dose | 160.42 | 47 |
GSM1296113 | Q_lesional_pre-dose | 110.41 | 40 |
GSM1296096 | R_lesional_pre-dose | 262.78 | 57 |
GSM1296105 | S_lesional_pre-dose | 308.52 | 59 |
GSM1296098 | T_lesional_pre-dose | 549.84 | 69 |
GSM1296101 | U_lesional_pre-dose | 386.46 | 63 |
GSM1296121 | V_lesional_pre-dose | 190.97 | 51 |
GSM1296088 | W_lesional_pre-dose | 452.75 | 66 |
GSM1296082 | X_lesional_pre-dose | 355.47 | 63 |
GSM1296115 | Y_lesional_pre-dose | 98.92 | 40 |
GSM1296084 | Z_lesional_pre-dose | 475.03 | 67 |
GSM1296072 | B_lesional_day8 | 178.9 | 50 |
GSM1296069 | L_lesional_day8 | 125.9 | 42 |
GSM1296071 | P_lesional_day8 | 175.46 | 48 |
GSM1296070 | Y_lesional_day8 | 108.66 | 40 |
GSM1296073 | V_lesional_day8 | 78.43 | 37 |
GSM1296034 | A_lesional_day15 | 706.37 | 73 |
GSM1296041 | G_lesional_day15 | 105.41 | 41 |
GSM1296035 | R_lesional_day15 | 305.51 | 59 |
GSM1296038 | U_lesional_day15 | 282.14 | 58 |
GSM1296047 | B_lesional_day15 | 169.99 | 48 |
GSM1296039 | E_lesional_day15 | 245.42 | 56 |
GSM1296042 | H_lesional_day15 | 165.6 | 48 |
GSM1296043 | L_lesional_day15 | 88.72 | 36 |
GSM1296037 | M_lesional_day15 | 347.02 | 61 |
GSM1296046 | P_lesional_day15 | 131.68 | 43 |
GSM1296044 | Q_lesional_day15 | 174.53 | 48 |
GSM1296045 | Y_lesional_day15 | 120.44 | 41 |
GSM1296025 | C_lesional_day15 | 562.53 | 70 |
GSM1296033 | D_lesional_day15 | 525.71 | 68 |
GSM1296027 | I_lesional_day15 | 879.48 | 77 |
GSM1296032 | J_lesional_day15 | 575.72 | 70 |
GSM1296024 | K_lesional_day15 | 498.03 | 68 |
GSM1296031 | W_lesional_day15 | 430.42 | 65 |
GSM1296028 | X_lesional_day15 | 650.14 | 72 |
GSM1296029 | Z_lesional_day15 | 695.93 | 73 |
GSM1296026 | F_lesional_day15 | 369.53 | 63 |
GSM1296030 | O_lesional_day15 | 718.19 | 73 |
GSM1296040 | S_lesional_day15 | 386.09 | 63 |
GSM1296036 | T_lesional_day15 | 515.82 | 67 |
GSM1296048 | V_lesional_day15 | 126.92 | 44 |
GSM1296059 | A_lesional_day43 | 296.98 | 59 |
GSM1296066 | G_lesional_day43 | 93.79 | 38 |
GSM1296060 | R_lesional_day43 | 320.22 | 60 |
GSM1296063 | U_lesional_day43 | 127.68 | 45 |
GSM1296064 | E_lesional_day43 | 158.25 | 49 |
GSM1296067 | H_lesional_day43 | 336.61 | 60 |
GSM1296062 | M_lesional_day43 | 517.2 | 68 |
GSM1296068 | Q_lesional_day43 | 190.7 | 49 |
GSM1296050 | C_lesional_day43 | 376.18 | 63 |
GSM1296057 | D_lesional_day43 | 421.96 | 64 |
GSM1296052 | I_lesional_day43 | 845.45 | 76 |
GSM1296054 | J_lesional_day43 | 538.54 | 68 |
GSM1296049 | K_lesional_day43 | 506.54 | 68 |
GSM1296055 | W_lesional_day43 | 211.19 | 52 |
GSM1296053 | X_lesional_day43 | 1049.37 | 80 |
GSM1296058 | Z_lesional_day43 | 357.37 | 62 |
GSM1296051 | F_lesional_day43 | 243.78 | 57 |
GSM1296056 | O_lesional_day43 | 236.98 | 56 |
GSM1296065 | S_lesional_day43 | 282.41 | 58 |
GSM1296061 | T_lesional_day43 | 541.76 | 68 |
GSM1296095 | A_non-lesional_pre-dose | 126.89 | 46 |
GSM1296120 | B_non-lesional_pre-dose | 184.33 | 50 |
GSM1296077 | C_non-lesional_pre-dose | 494.82 | 68 |
GSM1296093 | D_non-lesional_pre-dose | 727.33 | 74 |
GSM1296104 | E_non-lesional_pre-dose | 192.51 | 52 |
GSM1296079 | F_non-lesional_pre-dose | 414.02 | 65 |
GSM1296108 | G_non-lesional_pre-dose | 183.46 | 50 |
GSM1296110 | H_non-lesional_pre-dose | 233.46 | 53 |
GSM1296081 | I_non-lesional_pre-dose | 981.69 | 78 |
GSM1296091 | J_non-lesional_pre-dose | 394.38 | 64 |
GSM1296075 | K_non-lesional_pre-dose | 237.4 | 56 |
GSM1296112 | L_non-lesional_pre-dose | 175.89 | 48 |
GSM1296100 | M_non-lesional_pre-dose | 468.51 | 66 |
GSM1296087 | O_non-lesional_pre-dose | 929.34 | 78 |
GSM1296118 | P_non-lesional_pre-dose | 197.46 | 50 |
GSM1296114 | Q_non-lesional_pre-dose | 120.82 | 42 |
GSM1296097 | R_non-lesional_pre-dose | 346.17 | 61 |
GSM1296106 | S_non-lesional_pre-dose | 193.15 | 51 |
GSM1296102 | U_non-lesional_pre-dose | 363.78 | 61 |
GSM1296122 | V_non-lesional_pre-dose | 191.9 | 50 |
GSM1296089 | W_non-lesional_pre-dose | 427.65 | 64 |
GSM1296083 | X_non-lesional_pre-dose | 676.97 | 72 |
GSM1296116 | Y_non-lesional_pre-dose | 109.19 | 39 |
GSM1296085 | Z_non-lesional_pre-dose | 845.07 | 76 |